Skip to main content

Articles

Page 1 of 25

  1. BUP-XR (SUBLOCADE®) is the first buprenorphine extended-release subcutaneous injection approved in the USA for monthly treatment of moderate-to-severe opioid use disorder (OUD). Among patients with OUD, those who...

    Authors: Mark K. Greenwald, Katharina L. Wiest, Barbara R. Haight, Celine M. Laffont and Yue Zhao
    Citation: Harm Reduction Journal 2023 20:173
  2. This paper applies the theory of change model (Kotter in Harv Bus Rev 2:59–67, 1995; Moore et al. in Viet Nam J Public Health 1(1):66–75, 2013) to describe the pathway that lead to Australia’s first pill testi...

    Authors: David Caldicott, Toni Makkai, Malcolm McLeod, Stephanie Tzanetis and Gino Vumbaca
    Citation: Harm Reduction Journal 2023 20:172
  3. Bystander administration of naloxone is a critical strategy to mitigate opioid overdose mortality. To ensure bystanders’ willingness to carry and administer naloxone in response to a suspected overdose, it is ...

    Authors: Katherine R. Marks, Douglas R. Oyler, Justin C. Strickland, Jody Jaggers, Monica F. Roberts, Dustin K. Miracle, Chase Barnes, Feitong Lei, Amanda Smith, Eric Mackin, Martika C. Martin and Patricia R. Freeman
    Citation: Harm Reduction Journal 2023 20:171
  4. The Canadian drug supply has significantly increased in toxicity over the past few years, resulting in the worsening of the overdose crisis. A key initiative implemented during this crisis has been data monito...

    Authors: Melissa Perri, Triti Khorasheh, David Edward-Ooi Poon, Nat Kaminski, Sean LeBlanc, Leticia Mizon, Ashley Smoke, Carol Strike and Pamela Leece
    Citation: Harm Reduction Journal 2023 20:169
  5. The experiences and perceived support needs of harm reduction workers in the USA have been understudied. While previous research has explored staff burnout and role-related stress, there is a research gap arou...

    Authors: Katherine Hill, Katherine Dunham, Lauretta E. Grau and Robert Heimer
    Citation: Harm Reduction Journal 2023 20:168
  6. Interpersonal violence and opioid use disorder are significant and intersecting public health concerns in the USA. The current study evaluated the consequences associated with opioid use (e.g., physical, socia...

    Authors: Prachi H. Bhuptani, Lindsay M. Orchowski, Shannon R. Forkus, Noam G. Newberger and Nicole H. Weiss
    Citation: Harm Reduction Journal 2023 20:167
  7. Overdoses have surged in rural areas in the U.S. and globally for years, but harm reduction interventions have lagged. Overdose education and naloxone distribution (OEND) programs reduce overdose mortality, bu...

    Authors: Zora Kesich, Umedjon Ibragimov, Kelli Komro, Kenneth Lane, Melvin Livingston, April Young and Hannah L. F. Cooper
    Citation: Harm Reduction Journal 2023 20:166
  8. Women who inject drugs in Ukraine are disproportionately burdened by HIV. To help address the needs of this population, a greater understanding of how interventions may uniquely benefit women who inject drugs ...

    Authors: John Mark Wiginton, Robert Booth, Laramie R. Smith, Sajina Shakya, Cristina Espinosa da Silva, Thomas L. Patterson and Eileen V. Pitpitan
    Citation: Harm Reduction Journal 2023 20:165
  9. In Kenya, violence is common among people who inject drugs (PWID) living with HIV and their sexual and injecting partners and may lead to decreased uptake of HIV services, increased HIV risk behaviors, and inc...

    Authors: Sai Win Kyaw Htet Aung, Hanley Kingston, Loice W. Mbogo, Betsy Sambai, Aliza Monroe-Wise, Natasha T. Ludwig-Barron, David Bukusi, William Sinkele, Esther Gitau, Sarah Masyuko, Joshua T. Herbeck, Carey Farquhar and Brandon L. Guthrie
    Citation: Harm Reduction Journal 2023 20:164
  10. The rising rates of drug use-related complications call for a paradigm shift in the care for people who use drugs. While addiction treatment and harm reduction have historically been siloed in the US, co-locat...

    Authors: Margaret Shang, Brent Thiel, Jane M. Liebschutz, Kevin L. Kraemer, Ariana Freund and Raagini Jawa
    Citation: Harm Reduction Journal 2023 20:163
  11. Injectable opioid agonist treatment (iOAT) is an effective option to support people living with opioid use disorder (OUD) who have not sufficiently benefitted from oral OAT. However, iOAT has been criticised b...

    Authors: Zoe Friedmann, Hans-Tilmann Kinkel, Claudia Kühner, Andreas Zsolnai, Inge Mick and Annette Binder
    Citation: Harm Reduction Journal 2023 20:162
  12. The methodological part of the large-scale study on the psychosocial distress of young people in Slovenia focused on vulnerable young people who use drugs and explored the potential of online interventions in ...

    Authors: Matej Sande, Bojan Dekleva, Špela Razpotnik, Darja Tadič, Mija Marija Klemenčič Rozman and Jana Rapuš Pavel
    Citation: Harm Reduction Journal 2023 20:161
  13. Providing sterile drug smoking materials to people who use drugs can prevent the acquisition of infectious diseases and reduce overdose risk. However, there is a lack of understanding of how these practices ar...

    Authors: Abigail Tapper, Catherine Ahern, Zoe Graveline-Long, Noam G. Newberger and Jaclyn M. W. Hughto
    Citation: Harm Reduction Journal 2023 20:160
  14. Opioid overdose deaths are of great concern to public health, with over one million lives lost since 1999. While many efforts have been made to mitigate these, Black communities continue to experience a greate...

    Authors: Dong-Chul Seo, Naomi Satterfield, Leonardo Alba-Lopez, Shin Hyung Lee, Charlotte Crabtree and Nicki Cochran
    Citation: Harm Reduction Journal 2023 20:159
  15. Opioid withdrawal is a regular occurrence among many people who use illicit opioids (PWUIO) that has also been shown to increase their willingness to engage in risk-involved behavior. The proliferation of fent...

    Authors: David Frank, Luther Elliott, Charles M. Cleland, Suzan M. Walters, Paul J. Joudrey, Danielle M. Russell, Beth E. Meyerson and Alex S. Bennett
    Citation: Harm Reduction Journal 2023 20:158
  16. Research conducted in urban areas has highlighted the impact of housing instability on people who inject drugs (PWID), revealing that it exacerbates vulnerability to drug-related harms and impedes syringe serv...

    Authors: April M. Ballard, Dylan Falk, Harris Greenwood, Paige Gugerty, Judith Feinberg, Peter D. Friedmann, Vivian F. Go, Wiley D. Jenkins, P. Todd Korthuis, William C. Miller, Mai T. Pho, David W. Seal, Gordon S. Smith, Thomas J. Stopka, Ryan P. Westergaard, William A. Zule…
    Citation: Harm Reduction Journal 2023 20:157
  17. British Columbia (BC) has been facing a public health emergency of overdose since 2016, with rural regions of the province facing the highest rates of death. Peers (in this case, people with lived experience o...

    Authors: Marnie Scow, Jenny McDougall, Amanda Slaunwhite and Heather Palis
    Citation: Harm Reduction Journal 2023 20:156
  18. The Deadly Liver Mob (DLM) program is a peer-led health promotion program that aims to improve access to screening and treatment for blood borne viruses and sexually transmissible infections for Aboriginal and...

    Authors: Elena Cama, Kim Beadman, Mitch Beadman, Melinda Walker and Carla Treloar
    Citation: Harm Reduction Journal 2023 20:154
  19. The Deadly Liver Mob (DLM) is a peer-delivered incentivised health promotion program by and for Aboriginal and Torres Strait Islander Australians, and was introduced in response to the disproportionate number ...

    Authors: Carla Treloar, Kim Beadman, Mitch Beadman, Kerri-Anne Smith, Jade Christian, Aunty Clair Jackson, Beverley Tyson, Clayton Anderson, Larissa Smyth, Melinda Walker, Jennifer Heslop, Gary Gahan, Victor Tawil, Felicity Sheaves, Louise Maher, Julie Page…
    Citation: Harm Reduction Journal 2023 20:153
  20. We evaluated racial/ethnic differences in the receipt of naloxone distributed by opioid overdose prevention programs (OOPPs) in New York City (NYC).

    Authors: Shayla Nolen, Andrew J. Trinidad, Ashly E. Jordan, Traci C. Green, Ali Jalali, Sean M. Murphy, Xiao Zang, Brandon D. L. Marshall and Bruce R. Schackman
    Citation: Harm Reduction Journal 2023 20:152
  21. With many drug-related deaths driven by potent synthetic opioids tainting the illicit drug supply, drug checking services are becoming a key harm reduction strategy. Many drug checking technologies are availab...

    Authors: Chloe Grace Rose, A. Simon Pickard, Victoria Kulbokas, Stacey Hoferka, Kaitlyn Friedman, Jennifer Epstein and Todd A. Lee
    Citation: Harm Reduction Journal 2023 20:151
  22. Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD). The primary concern expressed by critics of these policies i...

    Authors: Joëlla W. Adams, Michael Duprey, Sazid Khan, Jessica Cance, Donald P. Rice and Georgiy Bobashev
    Citation: Harm Reduction Journal 2023 20:150
  23. Drug consumption rooms (DCRs) have been developed in cities with open drug scenes, with the aim to reduce drug-related harm. In Lyon, France's second-largest city, there is no distinct drug use area, which rai...

    Authors: Mathieu Chappuy, Philippe Lack, Baptiste David, Gilles Penavayre, Damien Thabourey, Maira Landulpho, Anthony Plasse, Christophe Icard, François Bailly, Faroudja Boutahra, Pierre Pradat, Marianne Maynard, Marie Jauffret-Roustide, Julia de Ternay and Benjamin Rolland
    Citation: Harm Reduction Journal 2023 20:149
  24. Despite law enforcement and health interventions, open drug scenes have led to problems in many countries. The problems are, however, insufficiently explored. There are different types of drug scenes in Iran. ...

    Authors: Sahar Eshrati, MohammadBagher Saberizafarghandi, Meroe Vameghi, Reza Arezoomandan, Hadi Ranjbar, Thomas Clausen and Helge Waal
    Citation: Harm Reduction Journal 2023 20:148
  25. Flavored e-cigarettes remain a controversial topic with regulators planning or already implementing restrictions worldwide. In this study, we examined patterns of flavor use in e-cigarettes among a convenience...

    Authors: Konstantinos Farsalinos, Christopher Russell, Riccardo Polosa, Konstantinos Poulas, George Lagoumintzis and Anastasia Barbouni
    Citation: Harm Reduction Journal 2023 20:147
  26. Social work with people who use drugs (PWUD) has traditionally focused on abstinence and rehabilitation. In recent years, harm reduction has gained an increasingly more important role in social work with PWUD,...

    Authors: Torkel Richert, Anke Stallwitz and Johan Nordgren
    Citation: Harm Reduction Journal 2023 20:146
  27. Most people who inject drugs (PWID) in Iran have not undergone recent HIV testing. While PWID face barriers when seeking HIV testing at health facilities, HIV self-testing (HIVST) could be a promising approach...

    Authors: Mehrdad Khezri, Emily Goldmann, Fatemeh Tavakoli, Mohammad Karamouzian, Mostafa Shokoohi, Soheil Mehmandoost, Nima Ghalekhani, Ali Akbar Haghdoost, Don Des Jarlais, Ali Mirzazadeh and Hamid Sharifi
    Citation: Harm Reduction Journal 2023 20:145
  28. Over 109,000 people in the USA died from a drug overdose in 2022. More alarming is the amount of drug overdose deaths involving synthetic opioids other than methadone (SOOM), primarily fentanyl. From 2015 to 2...

    Authors: Shawkut Amaan Ali, Jasmine Shell, Raymond Harris and Marshall Bedder
    Citation: Harm Reduction Journal 2023 20:144
  29. E-cigarettes (electronic nicotine delivery system, ENDS) have been presented as a harm reduction strategy for people who smoke tobacco cigarettes but who cannot achieve abstinence, or for those who wish to con...

    Authors: Maria Ahmed Qureshi, Robin W. M. Vernooij, Giusy Rita Maria La Rosa, Riccardo Polosa and Renee O’Leary
    Citation: Harm Reduction Journal 2023 20:143
  30. Due to concerns over potential interactions between some hepatitis C direct-acting antivirals (DAAs) and opioids, we describe adverse event (AE) reports of concomitant use of opioids and DAAs.

    Authors: Anthony Martinez, Tipu Khan, Douglas E. Dylla, John Marcinak, Michelle Collins, Brad Saget and Brian Conway
    Citation: Harm Reduction Journal 2023 20:142
  31. Xylazine has emerged as a consistent part of the unregulated drug supply in recent months. We discuss major domains of xylazine’s harm, current knowledge deficits, clinical and harm reduction strategies for mi...

    Authors: Claire M. Zagorski, Rebecca A. Hosey, Christopher Moraff, Aaron Ferguson, Mary Figgatt, Shoshana Aronowitz, Natalie E. Stahl, Lucas G. Hill, Zoe McElligott and Nabarun Dasgupta
    Citation: Harm Reduction Journal 2023 20:141

    The Correction to this article has been published in Harm Reduction Journal 2023 20:170

  32. Permanent supportive housing is an effective intervention for stably housing most people experiencing homelessness and mental illness who have complex support needs. However, high-risk behaviours and challenge...

    Authors: Nick Kerman, Sean A. Kidd, Christina Mutschler, John Sylvestre, Benjamin F. Henwood, Abe Oudshoorn, Carrie Anne Marshall, Tim Aubry and Vicky Stergiopoulos
    Citation: Harm Reduction Journal 2023 20:140
  33. The intersection of dual public health emergencies—the COVID-19 pandemic and the drug toxicity crisis—has led to an urgent need for acute care based harm reduction for unregulated opioid use. Emergency Departm...

    Authors: Sunny Jiao, Vicky Bungay, Emily Jenkins and Marilou Gagnon
    Citation: Harm Reduction Journal 2023 20:139
  34. Overdose prevention sites (OPS) are evidence-based interventions to improve public health, yet implementation has been limited in the USA due to a variety of legal impediments. Studies in various US settings h...

    Authors: Kristin E. Schneider, Glenna J. Urquhart, Saba Rouhani, Sean T. Allen, Miles Morris and Susan G. Sherman
    Citation: Harm Reduction Journal 2023 20:138
  35. To prevent the transmission of blood-borne infections and reach the elimination of viral hepatitis by 2030, the World Health Organization (WHO) has set the goal to distribute 300 sterile needles and syringes e...

    Authors: Franziska Hommes, Amrei Krings, Achim Dörre, Esther Neumeier, Dirk Schäffer and Ruth Zimmermann
    Citation: Harm Reduction Journal 2023 20:137
  36. Opioid relapse, one of the common and severe problems during methadone maintenance treatment, can give rise to poor treatment outcomes. This study measured the opioid relapse rate and its associated factors am...

    Authors: Huong Thi Thanh Nguyen and Dai Xuan Dinh
    Citation: Harm Reduction Journal 2023 20:136
  37. Meaningful engagement and partnerships with people who use drugs are essential to conducting research that is relevant and impactful in supporting desired outcomes of drug consumption as well as reducing drug-...

    Authors: Phoenix Beck McGreevy, Shawn Wood, Erica Thomson, Charlene Burmeister, Heather Spence, Josh Pelletier, Willow Giesinger, Jenny McDougall, Rebecca McLeod, Abby Hutchison, Kurt Lock, Alexa Norton, Brittany Barker, Karen Urbanoski, Amanda Slaunwhite, Bohdan Nosyk…
    Citation: Harm Reduction Journal 2023 20:135
  38. Opioid use disorder (OUD) poses significant public health problems that have increased dramatically, resulting in high rates of morbidity and mortality.

    Authors: Rozner Lihi, Delayahu Yael, Brill Silviu, Sason Anat, Weinstein Marsha, Shoshan Stacy, Schreiber Shaul, Adelson Miriam and Peles Einat
    Citation: Harm Reduction Journal 2023 20:134
  39. Syringe service programs (SSPs) provide tools to people who inject drugs (PWID) to prevent overdose, reduce the risk of HIV and HCV infection, and reduce injection frequency. While effective, previous research...

    Authors: Katheryn Salow, Helen E. Jack, Joe Tinsley, Caleb J. Banta-Green, Susan Kingston, Matthew Iles-Shih, Judith I. Tsui and Sara Glick
    Citation: Harm Reduction Journal 2023 20:133
  40. Little is known about perceptions, use intentions, and behaviors of adults regarding nicotine gum that is marketed and regulated as a consumer product rather than as a medicinal nicotine replacement therapy (N...

    Authors: Cheryl K. Olson, Neil Sherwood, Maia Berkane, Karin Gilligan and Willie J. McKinney Jr.
    Citation: Harm Reduction Journal 2023 20:132
  41. The French Addictovigilance network has observed the existence of the intravenous use of oral morphine capsules among people suffering from opioid use disorders. According to persons who inject morphine, these...

    Authors: Célian Bertin, Philémon Dècle, Pierre Chappard, Perrine Roux and Nicolas Authier
    Citation: Harm Reduction Journal 2023 20:130
  42. Safe Spaces are a harm reduction approach commonly utilised in nightlife and festival settings to address alcohol and other drug-related harms. Despite increasing use, there has been little independent evaluat...

    Authors: Phillip Wadds, Christopher M. Doran, Anthony Shakeshaft and Dam Anh Tran
    Citation: Harm Reduction Journal 2023 20:129
  43. The unintentional consumption of fentanyl is a serious health risk for people who use illicit drugs. In an ongoing community-based study regarding polysubstance use among people who use opioids, we found that ...

    Authors: Jennifer Lorvick, Jordana L. Hemberg, Madeleine J. George, Joy R. Piontak and Megan L. Comfort
    Citation: Harm Reduction Journal 2023 20:128
  44. Emerging adults have the highest cannabis consumption rates in Canada and are among the most vulnerable to cannabis-related harms. Since certain cannabis consumption behaviours carry greater risks of harm, the...

    Authors: Isobel McMahon, Laura M. Harris-Lane, Jennifer Donnan, Lisa Bishop and Nick Harris
    Citation: Harm Reduction Journal 2023 20:127
  45. Housing environments shape injection drug-related risks and harms and thus represent a critical implementation setting for syringe services programs (SSPs). As critical harm reduction measures, SSPs provide sa...

    Authors: Koharu Loulou Chayama, Cara Ng, Taylor Fleming, Will Small, Kimberly L. Sue and Ryan McNeil
    Citation: Harm Reduction Journal 2023 20:126
  46. Aboriginal and Torres Strait Islander Australians are disproportionately impacted by blood-borne viruses (BBVs) and sexually transmissible infections (STIs). Stigma remains one of the key barriers to testing a...

    Authors: Elena Cama, Kim Beadman, Mitch Beadman, Kerri-Anne Smith, Jade Christian, Aunty Clair Jackson, Beverley Tyson, Clayton Anderson, Larissa Smyth, Jennifer Heslop, Gary Gahan, Victor Tawil, Felicity Sheaves, Louise Maher, Julie Page, Donna Tilley…
    Citation: Harm Reduction Journal 2023 20:125
  47. People with substance use disorder are at risk of complications of drug use and frequent hospitalization and may continue to use substances during admission to acute care. Acute care harm reduction strategies ...

    Authors: Casey Wigg, Amy Nolen, Lisa Jauhal and Malika Sharma
    Citation: Harm Reduction Journal 2023 20:123